Novartis Investigative Site

Columbia, Tennessee 38401

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Forms of Multiple Sclerosis

Studies at this site

• A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis — Completed